Subscribe     Pay Now

Austria Project Notice - Therapeutic Hijacking Of E3 Ligases


Project Notice

PNR 41929
Project Name Therapeutic hijacking of E3 Ligases
Project Detail Molecular glues induce target protein degradation by cooperative binding to E3 ligases Recent discovery of the proteolysis-targeting chimeras (PROTACs), which are synthetic molecules recruiting target proteins to a ubiquitin ligase for ubiquitination and subsequent degradation, demonstrated how the rationally designed molecules enable targeting of a harmful protein substrate. The EU-funded project Glue2Degrade aims to transform the protein targeting in general, based on the hypothesis that molecular glues (MGs), small molecules that degrade target proteins through cooperative binding to E3 ligases, are much more prevalent than anticipated. Researchers will identify novel MGs and their E3 ligases by phenotypic discovery strategies and an orthogonal chemical genetics pipeline. The mechanisms of novel MGs will be studied using proteomics and chemical optimisation. Glue2Degrades success will advance the potential for therapeutic development of cell-, tissue- and cancer-type specific chemical degraders for undruggable proteins.
Funded By European Union (EU)
Sector
Country Austria , Western Europe
Project Value EUR 1,331,340

Contact Information

Company Name CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH
Address Lazarettgasse 14 Akh Bt 25.3 1090 Wien
Web Site https://cordis.europa.eu/project/id/851478

Tell us about your Product / Services,
We will Find Tenders for you